• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿普斯特原料药、制剂及生物体液分析方法的测定:文献综述。

Analytical Methods for Determination of Apremilast from Bulk, Dosage Form and Biological Fluids: A Critical Review.

机构信息

School of Pharmacy & Technology Management, SVKM's NMIMS, Shirpur, Maharashtra, India.

出版信息

Crit Rev Anal Chem. 2021;51(3):258-267. doi: 10.1080/10408347.2020.1718481. Epub 2020 Feb 5.

DOI:10.1080/10408347.2020.1718481
PMID:32024370
Abstract

Apremilast is an anti-inflammatory agent. It has been a flourishing molecule in the field of dermatology. In the year 2014, Apremilast got its approval for treatment of psoriatic arthritis. Presently it is known to treat a number of other conditions, including atopic dermatitis and plaque psoriasis. Apremilast a phthalimide derivative, is non-hygroscopic in nature. It is practically insoluble in water. Apremilast acts by inhibiting the activity of phosphodiesterase 4 (PDE4), an intracellular enzyme. Analytical method plays a key role to understand the physio-chemical properties of a drug molecule. Because of poor solubility and low permeability, analytical method development and formulation becomes challenging. Till date, there are no standard test methods available to analyze Apremilast. So, a critical review of the analytical techniques of Apremilast was carried out. The literature search was done by screening the papers reporting analytical techniques of Apremilast from year 2014 to 2019. Methodologies particularly UV spectroscopy, HPTLC, HPLC, X-ray diffraction, NMR, LC-MS were collected and reviewed. Interminable efforts are made by the researchers to develop simple, accurate, robust and cost-effective methods of analysis. In pharmaceutical research, this information will aid in the development of new delivery systems. The review will prove beneficial and advantageous pre-formulation studies and will guide the formulation development.

摘要

阿普司特是一种抗炎药。它在皮肤病学领域是一种很有前途的药物。2014 年,阿普司特获得批准用于治疗银屑病关节炎。目前,它已被证明可用于治疗多种其他疾病,包括特应性皮炎和斑块状银屑病。阿普司特是一种邻苯二甲酰亚胺衍生物,性质不易吸湿。实际上它在水中几乎不溶。阿普司特通过抑制细胞内酶磷酸二酯酶 4(PDE4)的活性起作用。分析方法对于了解药物分子的物理化学性质起着关键作用。由于溶解度差和渗透性低,分析方法的开发和制剂变得具有挑战性。到目前为止,还没有标准的测试方法可用于分析阿普司特。因此,对阿普司特的分析技术进行了批判性评价。通过筛选 2014 年至 2019 年报道阿普司特分析技术的论文,进行了文献检索。收集并综述了方法,特别是紫外光谱法、HPTLC、HPLC、X 射线衍射、NMR、LC-MS。研究人员进行了不懈的努力,以开发简单、准确、强大且具有成本效益的分析方法。在药物研究中,这些信息将有助于开发新的给药系统。该综述将证明对预配方研究有益和有利,并指导配方开发。

相似文献

1
Analytical Methods for Determination of Apremilast from Bulk, Dosage Form and Biological Fluids: A Critical Review.阿普斯特原料药、制剂及生物体液分析方法的测定:文献综述。
Crit Rev Anal Chem. 2021;51(3):258-267. doi: 10.1080/10408347.2020.1718481. Epub 2020 Feb 5.
2
Off-label studies on apremilast in dermatology: a review.阿普斯特在皮肤科的超适应证研究:综述。
J Dermatolog Treat. 2020 Mar;31(2):131-140. doi: 10.1080/09546634.2019.1589641. Epub 2019 Apr 2.
3
Apremilast: A Review in Psoriasis and Psoriatic Arthritis.阿普米司特:用于银屑病和银屑病关节炎的治疗。
Drugs. 2017 Mar;77(4):459-472. doi: 10.1007/s40265-017-0709-1.
4
Drug safety evaluation of apremilast for treating psoriatic arthritis.阿普司特治疗银屑病关节炎的药物安全性评估
Expert Opin Drug Saf. 2015 Jun;14(6):979-85. doi: 10.1517/14740338.2015.1031743. Epub 2015 Mar 31.
5
Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritis.阿普司特:一种用于治疗银屑病关节炎的磷酸二酯酶4(PDE4)抑制剂。
Expert Opin Pharmacother. 2015 May;16(7):1099-108. doi: 10.1517/14656566.2015.1034107. Epub 2015 Apr 11.
6
Apremilast in the treatment of psoriasis and psoriatic arthritis.阿普司特治疗银屑病和银屑病关节炎。
Skin Therapy Lett. 2015 Sep-Oct;20(5):1-6.
7
Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis.阿普司特与生物制剂联合治疗作为银屑病关节炎和银屑病的安全选择
Curr Rheumatol Rev. 2019;15(3):234-237. doi: 10.2174/1573397115666181130094455.
8
Apremilast: first global approval.阿普米司特:全球首次获批。
Drugs. 2014 May;74(7):825-37. doi: 10.1007/s40265-014-0218-4.
9
Safety evaluation of apremilast for the treatment of psoriasis.阿普米司特治疗银屑病的安全性评估。
Expert Opin Drug Saf. 2017 Mar;16(3):381-385. doi: 10.1080/14740338.2017.1288714. Epub 2017 Feb 7.
10
▼ Apremilast for psoriasis and psoriatic arthritis.▼ 阿普斯特用于治疗银屑病和银屑病关节炎。
Drug Ther Bull. 2015 Sep;53(9):105-8. doi: 10.1136/dtb.2015.9.0352.

引用本文的文献

1
Phthalimides as anti-inflammatory agents.邻苯二甲酰亚胺作为抗炎剂。
Future Med Chem. 2025 Jan;17(1):125-142. doi: 10.1080/17568919.2024.2437979. Epub 2024 Dec 17.
2
Effect of Penetration Enhancers and Safety on the Transdermal Delivery of Apremilast in Skin.渗透促进剂对阿普斯特经皮给药的影响及其在皮肤中的安全性
Pharmaceutics. 2022 May 7;14(5):1011. doi: 10.3390/pharmaceutics14051011.
3
COVID-19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast.对于接受阿普司特治疗的银屑病患者,新冠疫苗不会引发银屑病发作。
Clin Exp Dermatol. 2021 Oct;46(7):1344-1346. doi: 10.1111/ced.14723. Epub 2021 Jun 9.
4
Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies.采用超高效液相色谱-串联质谱法测定比格犬血浆中阿普米拉斯并将其应用于药代动力学研究
J Anal Methods Chem. 2021 Jan 15;2021:8881076. doi: 10.1155/2021/8881076. eCollection 2021.
5
Apremilast Microemulsion as Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation.阿普米拉斯微乳剂作为局部炎症的局部治疗:设计、表征及疗效评估。
Pharmaceuticals (Basel). 2020 Dec 21;13(12):484. doi: 10.3390/ph13120484.